| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4004811 | American Journal of Ophthalmology | 2008 | 6 Pages |
Abstract
Intravitreal bevacizumab may improve or stabilize VA in a significant majority of patients with neovascular complications of OHS (24 eyes [85.7%] in our study population).
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Ramin Schadlu, Kevin J. Blinder, Gaurav K. Shah, Nancy M. Holekamp, Matthew A. Thomas, M. Gilbert Grand, Nicholas E. Engelbrecht, Rajendra S. Apte, Daniel P. Joseph, Anita G. Prasad, Bradley T. Smith, Arsham Sheybani,